Home DTx Pharma

DTx Pharma

acquired
Series B
RNA Therapeutics R&D Company

Basic Information

DTx Pharma is committed to developing a method that can make RNA therapy more effective, unleashing RNA-based treatments as a modality choice for personalized medicine across most therapeutic areas.DTx believes its approach to delivering RNA therapeutics addresses some of the limitations of previous platforms, including poor pharmacokinetics and inadequate cellular uptake.
DTx Pharma, LLC.
SanDiego,California,United States of America
less than 15 people
January 01, 2017
--